Viral vector bioprocessing
Guest Editor:Anindya Dasgupta, Director, Vector Development at Expression Therapeutics
Director, Vector Development at Expression Therapeutics
Anindya is the director of vector development at Expression Therapeutics. He obtained his PhD from University of South Carolina. His post-doctoral training and research associateship at the school of medicine, Emory University, Atlanta were focussed on the evaluation of novel anti-cancer therapies and the development of strategies for expansion and lentivirus based bioengineering of T cells in serum free media . Anindya is a co-inventor of a patent on anti-cancer strategy. He was also the Director of Laboratory at KIYATEC Inc. At his recent role at Cincinnati Children’s Hospital Medical Centre he led vector development to manufacture high titer lentiviral vectors.